• The Korean Journal of Pain
• /
• 제32권1호
• /
• pp.30-38
• /
• 2019

Background: The adductor canal block (ACB) is an effective intervention for postoperative analgesia following total knee arthroplasty (TKA). However, the ideal ACB regimen has not yet been established. We compared the analgesic effects between a continuous ACB group and fentanyl-based intravenous patient-controlled analgesia (IV-PCA) with a single-shot ACB group. Methods: Patients who underwent TKA were randomly allocated to either a continuous ACB group (Group CACB) or IV-PCA with a single-shot ACB group (Group IVACB). Before the surgery, ultrasound guided ACB with 0.5% ropivacaine 20 cc was provided to all patients. Before skin incision, the infusion system (0.2% ropivacaine through an adductor canal catheter in group CACB vs. intravenous fentanyl in group IVACB) was connected. The postoperative pain severity; the side effects of local anesthetics and opioids; administration of rescue analgesics and anti-emetics; and sensorimotor deficits were measured. Results: Postoperative pain severity was significantly higher in the IVACB group at 30 min, 4 h, 24 h, and 48 h after surgery. The averages and standard deviations (SD) of the NRS score of postoperative pain were $0.14{\pm}0.37$, $4.57{\pm}2.37$, $6.00{\pm}1.63$, and $4.28{\pm}1.49$, respectively in the IVACB group. Rescue analgesic requirements and quadriceps muscle strength were not statistically different between the groups throughout the postoperative period. Moreover, rescue antiemetic requirements were higher in group IVACB than group CACB. Conclusions: In this study, the continuous ACB provided superior analgesia and fewer side effects without any significant motor deficit than the IV-PCA with a single-shot ACB.

• 농촌의학ㆍ지역보건
• /
• 제26권2호
• /
• pp.7-14
• /
• 2001

증례들은 40대 남자 1명과 여자 1명, 50대 여자 2명이었다. 담배 농사는 모두 10년 이상 종사하였다. 모두 어지러움과 구역을 호소하였으며, 구토, 두통, 설사, 쇠약감 등의 증상이 있었다. 이런 증상은 담배를 집중적으로 수확하는 시기에 발생하였으며, 날씨가 덥거나 땀을 많이 흘리는 경우에 증상이 심했다. 이슬에 젖은 담배잎을 수학하면서 증상이 발현되는 경우도 있었다. 최근 2-3년 동안에 상기 증상들이 1년에 2-3차례 발생하였다. 남자 1명이 고혈압으로 치료하고 있는 것을 제외하면 병력상 특이점은 없었으며, 모두 비흡연자였다. 증례들은 약국과 병원에서 수액요법 등으로 1일 이내에 호전되었다. 우리 나라에서 담배잎농부병의 유병률, 발생률 및 위험요인을 파악하기 위한 역학조사와 병 의원 감시체계를 가동하여야 한다. 담배잎을 수확하다가 어지러움과 구토를 주소로 내원하는 많은 사람들이 실제 담배잎농부병으로 진단되지 못하고 단순한 농약중독과 고온손상에 준하여 치료받는 경우가 많을 것으로 생각한다. 담배를 재배하는 농부는 물론 의료인에 대해서도 담배잎농부병의 예방과 치료에 대한 교육을 실시하여야 한다.

• Asian Pacific Journal of Cancer Prevention
• /
• 제13권8호
• /
• pp.4187-4190
• /
• 2012

Aims and Background: To evaluate the efficacy of a combination of aprepitant and conventional antiemetic therapy in patients with advanced or recurrent lung cancer receiving moderately emetogenic chemotherapy (MEC). Methods: Patients with advanced or recurrent lung cancer who were treated with MEC regimens at the Department of Respiratory Medicine, Fukuoka University Hospital, were included and classified into the following groups: control group (treatment: 5-HT3 receptor antagonists + dexamethasone) and aprepitant group (treatment: 5-HT3 receptor antagonists + dexamethasone + aprepitant). The presence or absence of chemotherapy-induced nausea and vomiting (CINV) was evaluated according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.0; patients with grade 1 or above were considered positive for CINV. Food intake per day, completion of planned chemotherapy, and progression-free survival (PFS) achieved by chemotherapy were investigated. Results: The complete suppression rate of nausea in the aprepitant group was significantly higher than that in the control group (p = 0.0043). Throughout the study, the food intake in the aprepitant group was greater than that in the control group, with the rate being significantly higher, in particular, on day 5 (p = 0.003). The completion rate of planned chemotherapy was also higher in the aprepitant group (p = 0.042). PFS did not differ significantly, but tended to be improved in the aprepitant group. Conclusions: The aprepitant group showed significantly higher complete suppression of nausea, food intake on day 5, and completion of planned chemotherapy than the control group.